Literature DB >> 27165202

Analysis of CYP17, CYP19 and CYP1A1 Gene Polymorphisms in Iranian Women with Breast Cancer.

Farah Farzaneh1, Giti Noghabaei, Esmat Barouti, Farkhondeh Pouresmaili, Javad Jamshidi, Atena Fazeli, Babak Emamalizadeh, Hossein Darvish.   

Abstract

Breast cancer (BC) is the most common cancer and the second cause of mortality in women all around the world. It is caused by several factors including genetic determinants, so that both genetic susceptibility factors and environmental factors are involved in the etiology. Significance of genes functioning in steroid hormone synthesis and metabolism are well established in breast cancer susceptibility. In this study, 134 women with BC and 135 normal controls were analyzed for their genotypes for the polymorphisms, rs743572, rs10046 and rs4646903, resided in CYP17, CYP19 and CYP1A1 genes, respectively. Significant differences in distributions of allele and genotype frequencies were found for the rs10046 polymorphism in CYP19 (p-value=0.01, OR (CI 95%) =1.59 (1.1-2.3), p-value=0.04, OR (CI 95%) =1.7 (1.1-2.5) respectively). For rs743,572 and rs 4646903 polymorphisms, no significant associations were observed. A significant association was observed between the rs10046 polymorphism of the CYP19gene and breast cancer in Iranian patients. Due to inconsistent previous results, more studies in different populations with larger sample sizes are indicated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27165202     DOI: 10.7314/apjcp.2016.17.s3.23

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Association between CYP17 T-34C rs743572 and breast cancer risk.

Authors:  Jing Sun; Hong Zhang; Meiyan Gao; Zhishu Tang; Dongyan Guo; Xiaofei Zhang; Zhu Wang; Ruiping Li; Yan Liu; Wansen Sun; Xi Sun
Journal:  Oncotarget       Date:  2017-12-26

2.  Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: a retrospective study.

Authors:  Yi-Xuan Zhao; Shuang Liu; Yan-Bing Hu; Yan-Yan Ge; Dong-Mei Lv
Journal:  Onco Targets Ther       Date:  2017-02-22       Impact factor: 4.147

3.  Diagnostic and prognostic values of contrast‑enhanced ultrasound combined with diffusion‑weighted magnetic resonance imaging in different subtypes of breast cancer.

Authors:  Gui-Feng Liu; Zong-Qiang Wang; Shu-Hua Zhang; Xue-Feng Li; Lin Liu; Ying-Ying Miao; Shao-Nan Yu
Journal:  Int J Mol Med       Date:  2018-03-27       Impact factor: 4.101

4.  Association of CYP1A1 M2 (A2455G) Polymorphism with Susceptibility to Breast Cancer in Mazandaran Province, Northern Iran: A Case-control Study.

Authors:  Ghazaleh Khalili-Tanha; Ali Barzegar; Novin Nikbakhsh; Zarbakht Ansari-Pirsaraei
Journal:  Int J Prev Med       Date:  2019-06-07

Review 5.  Genetic and molecular biology of breast cancer among Iranian patients.

Authors:  Meysam Moghbeli
Journal:  J Transl Med       Date:  2019-07-08       Impact factor: 5.531

6.  The impact of CYP19A1 variants and haplotypes on breast cancer risk, clinicopathological features and prognosis.

Authors:  Ahmad Mohammed Alwan; Fahimeh Afzaljavan; Jalil Tavakol Afshari; Fatemeh Homaei Shandiz; Matineh Barati Bagherabad; Elham Vahednia; Nahid Kheradmand; Alireza Pasdar
Journal:  Mol Genet Genomic Med       Date:  2021-05-20       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.